Dolichospondylic dysplasia
Dolichospondylic Dysplasia Dolichospondylic dysplasia is a rare genetic disorder characterized by distinctive skeletal abnormalities. This condition is part of a group of disorders known as spondyloepiphyseal dysplasias, which affect the bones of the spine and the ends of long bones.
Clinical Features[edit | edit source]
Individuals with dolichospondylic dysplasia typically present with:
- Short stature: Due to abnormal growth of the spine and long bones.
- Spinal abnormalities: Including scoliosis and kyphosis.
- Joint laxity: Leading to increased flexibility and potential joint dislocations.
- Facial dysmorphism: Such as a prominent forehead and midface hypoplasia.
Genetic Basis[edit | edit source]
Dolichospondylic dysplasia is caused by mutations in specific genes that are crucial for bone development. The exact genetic mutations can vary, and genetic testing is often required to confirm a diagnosis.
Diagnosis[edit | edit source]
Diagnosis of dolichospondylic dysplasia involves:
- Clinical evaluation: Assessment of physical symptoms and family history.
- Radiographic imaging: X-rays to identify characteristic skeletal abnormalities.
- Genetic testing: To identify mutations associated with the disorder.
Management[edit | edit source]
There is no cure for dolichospondylic dysplasia, but management focuses on alleviating symptoms and improving quality of life:
- Orthopedic interventions: Such as bracing or surgery to correct spinal deformities.
- Physical therapy: To improve mobility and strengthen muscles.
- Regular monitoring: To manage complications and adjust treatment as needed.
Prognosis[edit | edit source]
The prognosis for individuals with dolichospondylic dysplasia varies depending on the severity of symptoms and the presence of complications. With appropriate management, many individuals can lead active lives.
Research and Future Directions[edit | edit source]
Ongoing research aims to better understand the genetic mechanisms underlying dolichospondylic dysplasia and to develop targeted therapies. Advances in genetic engineering and personalized medicine hold promise for future treatments.
See Also[edit | edit source]
External Links[edit | edit source]
NIH genetic and rare disease info[edit source]
Dolichospondylic dysplasia is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
